ECOR 13.49 (+5.97%)
US28531P1030• Medical Devices & Instruments• Medical Instruments & Supplies
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. ECOR

ElectroCore (ECOR) Competitor Comparison

We are evaluating the key criteria listed to compare ElectroCore (ECOR) against its competitors in the Medical Instruments & Supplies industry.

Market Capitalization

37 / 44

Gross Profits

35 / 40

Total Revenue

38 / 43

EBITDA

37 / 44

Free Cashflow

37 / 44

Quick Ratio

29 / 44

Earnings per Share

36 / 44

Dividend yield

0 / 13

Total Cash

34 / 44

Performance 3 years

15 / 44

Performance 5 years

30 / 44

Performance 10 years

40 / 44

Linearity 3 years

3 / 43

Linearity 5 years

25 / 44

Linearity 10 years

28 / 43

Total Rank

33 / 44

Dividend Rank

11 / 44

Valuation Rank

2 / 44

Piotroski Rank

36 / 44

Muliplier Rank

38 / 44

Total Rank - ECOR ranking 33 / 44

These are the competitors of ElectroCore in the industry Medical Instruments & Supplies ranked by total rank
1. Hologic HOLX
4
2. ResMed RMD
3
3. Ansell PD1.F
3
4. Bausch & Lomb BLCO
3
5. West Pharmaceutical Services WST
3
6. Baxter BAX
3
7. Envista Holdings NVST
3
8. Teleflex TFX
3
9. Becton, Dickinson BDX
3
10. Merit Medical Systems MMSI
3
11. Masimo MASI
3
12. ICU Medical ICUI
2
13. Intuitive Surgical ISRG
2
14. iRhythm Technologies IRTC
2
15. KORU Medical Systems KRMD
2
16. LeMaitre Vascular LMAT
2
17. Nephros NEPH
2
18. NeuroMetrix NURO
2
19. NexGel NXGL
2
20. NovoCure NVCR
2
21. OraSure Technologies OSUR
2
22. Predictive Oncology POAI
2
23. Pro-Dex PDEX
2
24. Pulse Biosciences PLSE
2
25. Repligen RGEN
2
26. Steris STE
2
27. Alcon ALC
2
28. AngioDynamics ANGO
2
29. AtriCure ATRC
2
30. Atrion ATRI
2
31. BioLife Solutions BLFS
2
32. Dentsply Sirona XRAY
2
33. electroCore ECOR
2
34. Glaukos GKOS
2
35. Haemonetics HAE
2
36. Harvard Bioscience HBIO
2
37. Staar Surgical STAA
2
38. Cooper Companies COO
2
39. Utah Medical Products UTMD
2
40. Warby Parker WRBY
2
41. Microbot Medical MBOT
1
42. Ekso Bionics Holdings EKSO
1
43. Akoya Biosciences AKYA
1
44. Femasys FEMY
1
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.